Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Novartis Interested in Expanding Globally in Vaccines, FuW Says

Dec. 1 (Bloomberg) -- Novartis AG’s vaccine unit is interested in acquisitions that enable global expansion rather those that provide new products, Finanz und Wirtschaft said, citing an interview with the unit’s head, Andrin Oswald.

The size of a possible acquisition could be between $100 million and $200 million, the newspaper cited Oswald as saying. Novartis doesn’t need to buy vaccine products because it has a full pipeline, Oswald is quoted as saying in the newspaper.

To contact the reporter on this story: Eva von Schaper in Munich at evonschaper@bloomberg.net;

To contact the editor responsible for this story: Phil Serafino at pserafino@bloomberg.net.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.